Cargando…
Correction to: Incorporating radiomics into clinical trials: expert consensus endorsed by the European Society of Radiology on considerations for data-driven compared to biologically driven quantitative biomarkers
Autores principales: | Fournier, Laure, Costaridou, Lena, Bidaut, Luc, Michoux, Nicolas, Lecouvet, Frederic E., de Geus-Oei, Lioe-Fee, Boellaard, Ronald, Oprea-Lager, Daniela E., Obuchowski, Nancy A, Caroli, Anna, Kunz, Wolfgang G., Oei, Edwin H., O’Connor, James P. B., Mayerhoefer, Marius E., Franca, Manuela, Alberich-Bayarri, Angel, Deroose, Christophe M., Loewe, Christian, Manniesing, Rashindra, Caramella, Caroline, Lopci, Egesta, Lassau, Nathalie, Persson, Anders, Achten, Rik, Rosendahl, Karen, Clement, Olivier, Kotter, Elmar, Golay, Xavier, Smits, Marion, Dewey, Marc, Sullivan, Daniel C., van der Lugt, Aad, deSouza, Nandita M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8270880/ https://www.ncbi.nlm.nih.gov/pubmed/33693997 http://dx.doi.org/10.1007/s00330-021-07721-3 |
Ejemplares similares
-
Incorporating radiomics into clinical trials: expert consensus endorsed by the European Society of Radiology on considerations for data-driven compared to biologically driven quantitative biomarkers
por: Fournier, Laure, et al.
Publicado: (2021) -
Standardised lesion segmentation for imaging biomarker quantitation: a consensus recommendation from ESR and EORTC
por: deSouza, Nandita M., et al.
Publicado: (2022) -
Impact of the COVID-19 crisis on imaging in oncological trials
por: Deroose, Christophe M., et al.
Publicado: (2020) -
Bone Metastases Are Measurable: The Role of Whole-Body MRI and Positron Emission Tomography
por: Oprea-Lager, Daniela E., et al.
Publicado: (2021) -
Twenty Years On: RECIST as a Biomarker of Response in Solid Tumours an EORTC Imaging Group – ESOI Joint Paper
por: Fournier, Laure, et al.
Publicado: (2022)